Potential biomarkers of an exaggerated response to endotoxemia

References

• Adam BL, Qu Y, Davis JW, Ward MD, Clements MA, Cazares LH, Semmes OJ, Schellhammer PF, Yasui Y, Feng Z, Wright GL, Jr. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Research 2002; 62: 3609–3614
   PubMed Web of Science ®Google Scholar
• Adkins JN, Varnum SM, Auberry KJ, Moore RJ, Angell NH, Smith RD, Springer DL, Pounds JG. Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Molecular & Cell Proteomics 2002; 1: 947–955
   PubMed Web of Science ®Google Scholar
• Alessandro R, Belluco C, Kohn EC. Proteomic approaches in colon cancer: promising tools for new cancer markers and drug target discovery. Clinical Colorectal Cancer 2005; 4: 396–402
   PubMedGoogle Scholar
• Baggerly KA, Morris JS, Coombes KR 2004. Reproducibility of SELDI-TOF protein patterns in serum: comparing data sets from different experiments. Bioinformatics, 20:777–785
   PubMed Web of Science ®Google Scholar
• Baggerly KA, Morris JS, Edmonson SR, Coombes KR. Signal in noise: evaluating reported reproducibility of serum proteomic tests for ovarian cancer. Journal of the National Cancer Institute 2005; 97: 307–309
   PubMed Web of Science ®Google Scholar
• Bondarenko PV, Cockrill SL, Watkins LK, Cruzado ID, Macfarlane RD. Mass spectral study of polymorphism of the apolipoproteins of very low density lipoprotein. Journal of Lipid Research 1999; 40: 543–555
   PubMed Web of Science ®Google Scholar
• Brower MS, Harpel PC. Proteolytic cleavage and inactivation of alpha 2-plasmin inhibitor and C1 inactivator by human polymorphonuclear leukocyte elastase. Journal of Biological Chemistry 1982; 257: 9849–9854
   PubMed Web of Science ®Google Scholar
• Caliezi C, Wuillemin WA, Zeerleder S, Redondo M, Eisele B, Hack CE. C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema. Pharmacological Reviews 2000; 52: 91–112
   PubMed Web of Science ®Google Scholar
• Check E. Proteomics and cancer: running before we can walk?. Nature 2004; 429: 496–497
   PubMed Web of Science ®Google Scholar
• Chien JY, Jerng JS, Yu CJ, Yang PC. Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis. Critical Care Medicine 2005; 33: 1688–1693
   PubMed Web of Science ®Google Scholar
• Dayal B, Ertel NH. ProteinChip technology: a new and facile method for the identification and measurement of high-density lipoproteins apoA-I and apoA-II and their glycosylated products in patients with diabetes and cardiovascular disease. Journal of Proteome Research 2002; 1: 375–380
   PubMed Web of Science ®Google Scholar
• Deitch EA. Animal models of sepsis and shock: a review and lessons learned. Shock 1998; 9: 1–11
   PubMed Web of Science ®Google Scholar
• Derhaschnig U, Bergmair D, Marsik C, Schlifke I, Wijdenes J, Jilma B. Effect of interleukin-6 blockade on tissue factor-induced coagulation in human endotoxemia. Critical Care Medicine 2004; 32: 1136–1140
   PubMed Web of Science ®Google Scholar
• Derhaschnig U, Pernerstorfer T, Knechtelsdorfer M, Hollenstein U, Panzer S, Jilma B. Evaluation of antiinflammatory and antiadhesive effects of heparins in human endotoxemia. Critical Care Medicine 2003; 31: 1108–1112
   PubMed Web of Science ®Google Scholar
• Fink MP, Heard SO. Laboratory models of sepsis and septic shock. Journal of Surgical Research 1990; 49: 186–196
   PubMed Web of Science ®Google Scholar
• Fiuza C, Suffredini AF. Human models of innate immunity: local and systemic inflammatory responses. Journal of Endotoxin Research 2001; 7: 385–388
   PubMedGoogle Scholar
• Gillespie M. Affordable proteomics: the two-hybrid systems. Current Opinion in Molecular Therapeutics 2003; 5: 266–270
   PubMedGoogle Scholar
• Grossman HB, Messing E, Soloway M, Tomera K, Katz G, Berger Y, Shen Y. Detection of bladder cancer using a point-of-care proteomic assay. Journal of the American Medical Association 2005; 293: 810–816
   PubMed Web of Science ®Google Scholar
• Hansel A, Heinemann SH, Hoshi T. Heterogeneity and function of mammalian MSRs: enzymes for repair, protection and regulation. Biochimica et Biophysica Acta 2005; 1703: 239–247
   PubMed Web of Science ®Google Scholar
• Hari-Dass R, Shah C, Meyer DJ, Raynes JG. Serum amyloid A protein binds to outer membrane protein A of gram-negative bacteria. Journal of Biological Chemistry 2005; 280: 18562–18567
   PubMed Web of Science ®Google Scholar
• Hollenstein U, Homoncik M, Knobl P, Pernerstorfer T, Graggaber J, Eichler HG, Handler S, Jilma B. Acenocoumarol decreases tissue factor-dependent coagulation during systemic inflammation in humans. Clinical Pharmacology & Therapeutics 2002; 71: 368–374
   PubMed Web of Science ®Google Scholar
• Jacquemier J, Ginestier C, Rougemont J, Bardou VJ, Charafe-Jauffret E, Geneix J, Adelaide J, Koki A, Houvenaeghel G, Hassoun J, Maraninchi D, Viens P, Birnbaum D, Bertucci F, et al. Protein expression profiling identifies subclasses of breast cancer and predicts prognosis. Cancer Research 2005; 65: 767–779
   PubMed Web of Science ®Google Scholar
• Jilma B, Marsik C, Kovar F, Wagner OF, Jilma-Stohlawetz P, Endler G. The single nucleotide polymorphism Ser128Arg in the E-selectin gene is associated with enhanced coagulation during human endotoxemia. Blood 2005; 105: 2380–2383
   PubMed Web of Science ®Google Scholar
• Jilma B, Marsik C, Mayr F, Graninger MT, Taylor FB, Jr, Ribel MC, Erhardtsen E, Handler S, Eichler HG. Pharmacodynamics of active site-inhibited factor VIIa in endotoxin-induced coagulation in humans. Clinical Pharmacology & Therapeutics 2002; 72: 403–410
   PubMed Web of Science ®Google Scholar
• Kiernan UA, Tubbs KA, Nedelkov D, Niederkofler EE, Nelson RW. Detection of novel truncated forms of human serum amyloid A protein in human plasma. FEBS Letters 2003; 537: 166–170
   PubMed Web of Science ®Google Scholar
• Le Bihan T, Duewel HS, Figeys D. On-line strong cation exchange micro-HPLC-ESI-MS/MS for protein identification and process optimization. Journal of the American Society for Mass Spectrometry 2003; 14: 719–727
   PubMed Web of Science ®Google Scholar
• Liao H, Wu J, Kuhn E, Chin W, Chang B, Jones MD, O'Neil S, Clauser KR, Karl J, Hasler F, Roubenoff R, Zolg W, Guild BC. Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthritis & Rheumatism 2004; 50: 3792–3803
   PubMed Web of Science ®Google Scholar
• Moore F. Complement. ASM Press, Washington, DC 2004
   Google Scholar
• Nelsestuen GL, Martinez MB, Hertz MI, Savik K, Wendt CH. Proteomic identification of human neutrophil alpha-defensins in chronic lung allograft rejection. Proteomics 2005a; 5: 1705–1713
   PubMed Web of Science ®Google Scholar
• Nelsestuen GL, Zhang Y, Martinez MB, Key NS, Jilma B, Verneris M, Sinaiko A, Kasthuri RS. Plasma protein profiling: unique and stable features of individuals. Proteomics 2005b; 5: 4012–4024
   PubMed Web of Science ®Google Scholar
• Nuijens JH, Eerenberg-Belmer AJ, Huijbregts CC, Schreuder WO, Felt-Bersma RJ, Abbink JJ, Thijs LG, Hack CE. Proteolytic inactivation of plasma C1-inhibitor in sepsis. Journal of Clinical Investigation 1989; 84: 443–450
   PubMed Web of Science ®Google Scholar
• Pajkrt D, Doran JE, Koster F, Lerch PG, Arnet B, van der Poll T, ten Cate JW, van Deventer SJ. Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia. Journal of Experimental Medicine 1996; 184: 1601–1608
   PubMed Web of Science ®Google Scholar
• Pajkrt D, Lerch PG, van der Poll T, Levi M, Illi M, Doran JE, Aenet B, van den Ende A, ten Cate JW, van Deventer SJ. Differential effects of reconstituted high-density lipoprotein on coagulation, fibrinolysis and platelet activation during human endotoxemia. Thrombosis & Haemostasis 1997; 77: 303–307
   PubMed Web of Science ®Google Scholar
• Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC, Loitta LA. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002a; 359: 572–577
   PubMed Web of Science ®Google Scholar
• Petricoin EF III, Ornstein DK, Paweletz CP, et al. Serum proteomic patterns for detection of prostate cancer. Journal of the National Cancer Institute 2002b; 94: 1576–1578
   PubMed Web of Science ®Google Scholar
• Pieper R, Gatlin CL, Makusky AJ, Ardekani A, Hackett PS, Hitt BA, Velassco A, Trucco C, Wiegand L, Wood K, Simone CB, Levine PJ, Linehan WM, Emmert-Buck MR, Steinberg SM, Kohn EC, Liotta LA. The human serum proteome: display of nearly 3700 chromatographically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins. Proteomics 2003; 3: 1345–1364
   PubMed Web of Science ®Google Scholar
• Pleiner J, Schaller G, Mittermayer F, Zorn S, Marsik C, Polterauer S, Kapiotis S, Wolzt M. Simvastatin prevents vascular hyporeactivity during inflammation. Circulation 2004; 110: 3349–3354
   PubMed Web of Science ®Google Scholar
• Poon TC, Hui AY, Chan HL, Ang IL, Chow SM, Wong N, Sung JJ. Prediction of liver fibrosis and cirrhosis in chronic hepatitis B infection by serum proteomic fingerprinting: a pilot study. Clinical Chemistry 2005; 51: 328–335
   PubMed Web of Science ®Google Scholar
• Schroder NW, Schumann RR. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infectious Diseases 2005; 5: 156–164
   PubMed Web of Science ®Google Scholar
• Schultz MJ, van der Poll T. Animal and human models for sepsis. Annals of Medicine 2002; 34: 573–581
   PubMed Web of Science ®Google Scholar
• Stein PE, Carrell RW. What do dysfunctional serpins tell us about molecular mobility and disease?. Nature Structural Biology 1995; 2: 96–113
   PubMedGoogle Scholar
• Suffredini AF, Fantuzzi G, Badolato R, Oppenheim JJ, O'Grady NP. New insights into the biology of the acute phase response. Journal of Clinical Immunology 1999; 19: 203–214
   PubMed Web of Science ®Google Scholar
• Uhlar CM, Whitehead AS. Serum amyloid A, the major vertebrate acute-phase reactant. European Journal of Biochemistry 1999; 265: 501–523
   PubMedGoogle Scholar
• van Deventer SJ, Buller HR, ten Cate JW, Aarden LA, Hack CE, Sturk A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 1990; 76: 2520–2526
   PubMed Web of Science ®Google Scholar
• Villar J, Maca-Meyer N, Perez-Mendez L, Flores C. Bench-to-bedside review: understanding genetic predisposition to sepsis. Critical Care 2004; 8: 180–189
   PubMed Web of Science ®Google Scholar
• Walport MJ. Complement. Part I. New England Journal of Medicine 2001a; 344: 1058–1066
   PubMed Web of Science ®Google Scholar
• Walport MJ. Complement. Part II. New England Journal of Medicine 2001b; 344: 1140–1144
   PubMed Web of Science ®Google Scholar
• Wichterman KA, Baue AE, Chaudry IH. Sepsis and septic shock – a review of laboratory models and a proposal. Journal of Surgical Research 1980; 29: 189–201
   PubMed Web of Science ®Google Scholar
• Wurfel MM, Park WY, Radella F, et al. Identification of high and low responders to lipopolysaccharide in normal subjects: an unbiased approach to identify modulators of innate immunity. Journal of Immunology 2005; 175: 2570–2578
   PubMed Web of Science ®Google Scholar